The Spectrum of Biochemical Alterations with Molecular and Serological Biomarkers in the Diagnosis of COVID-19: Searching for Novel One to Identify Disease Earlier with Better Prognosis and Drug Discovery-Reference-Cited by-同舟云学术

The Spectrum of Biochemical Alterations with Molecular and Serological Biomarkers in the Diagnosis of COVID-19: Searching for Novel One to Identify Disease Earlier with Better Prognosis and Drug Discovery

Published:2021-11 Issue:3 Volume:16 Page:179-181
ISSN:2772-4344
Container-title:Recent Advances in Anti-Infective Drug Discovery
language:en
Short-container-title:RAAIDD

Author:

Ray Suman Kumar¹^ORCID,Mukherjee Sukhes²

Affiliation:

1. Independent Researcher,India

2. Department of Biochemistry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh 462020,India

Abstract

: Clinical and laboratory predictors of progression to serious and deadly forms are crucial in the fight against COVID-19, which has now become a worldwide pandemic. The clinical laboratory's vital role in today's crises has never been more obvious. These subjective clinical signals can be perceived more confidently during an examination with the help of biomarkers. To best combat present and future pandemics, global unity on test access is required, as well as infection prevention and diagnostic measures that are tightly linked.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery

Reference8 articles.

1. Phua J.; Weng L.; Ling L.; Egi M.; Lim C.M.; Divatia J.V.; Shrestha B.R.; Arabi Y.M.; Ng J.; Gomersall C.D.; Nishimura M.; Koh Y.; Du B.; Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020,8(5),506-517

2. Vandenberg O.; Martiny D.; Rochas O.; van Belkum A.; Kozlakidis Z.; Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol 2021,19(3),171-183

3. Malik P.; Patel U.; Mehta D.; Patel N.; Kelkar R.; Akrmah M.; Gabrilove J.L.; Sacks H.; Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 2021,26(3),107-108

4. Kermali M.; Khalsa R.K.; Pillai K.; Ismail Z.; Harky A.; The role of biomarkers in diagnosis of COVID-19 - A systematic review. Life Sci 2020,254,117788

5. Faustini S.E.; Jossi S.E.; Perez-Toledo M.; Shields A.; Allen J.D.; Watanabe Y.; Newby M.L.; Cook A.; Willcox C.R.; Salim M.; Goodall M.; Heaney J.L.; Marcial-Juarez E.; Morley G.L.; Torlinska B.; Wraith D.C.; Veenith T.; Harding S.; Jolles S.; Mark P.J.; Plant T.; Huissoon A.; O’Shea M.K.; Willcox B.E.; Drayson M.T.; Crispin M.; Cunningham A.F.; Richter A.G.; Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv 2020,[pre print article]

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytoconstitutents from Indian medicinal plants show therapeutic potential to combat COVID-19 by bind to SARS CoV-2 Main Protease (Mpro);2023-10-31

2. Severity-onset prediction of COVID-19 via artificial-intelligence analysis of multivariate factors;Heliyon;2023-08

3. A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?;Infectious Disorders - Drug Targets;2023-03

4. A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding Onwards;Infectious Disorders - Drug Targets;2022-09

5. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference;Infectious Disorders - Drug Targets;2022-06